Importantly, NLRC4 inflammasome activation has been involved in several metabolic diseases such as colitis‐associated tumorigenesis [16], obesity‐associated breast cancer progression, non‐alcoholic steatohepatitis (NASH), diabetic nephropathy (DN) and type 1 diabetes (T1D). Here, NLRC4 is linked to type 1 diabetes mellitus.